Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993–2000 to 2001–2006 in Japan [PDF]
Journal of Epidemiology, 2018 Background: Medical circumstances in Japanese patients with cancer of the corpus uteri have greatly changed since the late 1990s, including the introduction of concomitant therapy with taxane and platinum.
Shusaku Inoue +14 more
doaj +4 more sources
Clinical outcome analysis of modified B-Lynch sutures in the fundus uteri and part of the corpus uteri for the prevention of intraoperative haemorrhage during caesarean delivery in women with twin pregnancy: a retrospective study [PDF]
BMC Pregnancy and Childbirth, 2023 Objective To explore the efficacy of modified B-Lynch sutures in the fundus uteri and part of the corpus uteri for the prevention of intraoperative haemorrhage during caesarean delivery in women with twin pregnancy.
Chunbo Shi, Jinliang Chen, Aner Chen
doaj +3 more sources
Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016 [PDF]
Medicina, 2020 Background: The corpus uteri and ovarian cancers burden in Lithuania has remained high. The aim of this study was to investigate time trends in mortality rates of corpus uteri and ovarian cancer in Lithuania across age groups and time periods over a 30 ...
Rūta Everatt, Birutė Intaitė
doaj +3 more sources
Cancer of the corpus uteri: 2021 update. [PDF]
Int J Gynaecol Obstet, 2021 AbstractEndometrial cancer is the most common gynecological malignancy in high‐ and middle‐income countries. Although the overall prognosis is relatively good, high‐grade endometrial cancers have a tendency to recur. Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal.
Koskas M +3 more
europepmc +7 more sources
Cancer of the corpus uteri [PDF]
International Journal of Gynecology & Obstetrics, 2018 AbstractEndometrial cancer is the most common gynecological malignancy in high‐income countries. Although the overall prognosis is relatively good, high‐grade endometrial cancers have a tendency to recur. Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal.
Frédéric Amant +3 more
semanticscholar +11 more sources
Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension [PDF]
BMC CancerBackground Arterial hypertension is one of the most frequent comorbidities in patients with cancer. Studies have indicated that drugs used to control hypertension may alter cancer patient survival; however, epidemiological findings for their impact on ...
Rūta Everatt +6 more
europepmc +3 more sources
Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri [PDF]
Int J Mol Sci, 2019 Utilization of liquid biopsy in the management of cancerous diseases is becoming more attractive. This method can overcome typical limitations of tissue biopsies, especially invasiveness, no repeatability, and the inability to monitor responses to ...
Dana Dvorská +4 more
europepmc +3 more sources
Features of some transcription factors gene expression in the malignancy tissues of the corpus uteri
Успехи молекулярной онкологии, 2019 Background. Worldwide, more than 300,000 women are diagnosed with uterine cancer each year. Currently, the problem of finding highly specific molecular tumor markers for this disease remains relevant.
D. S. Kutilin, I. S. Nikitin, O. I. Kit
doaj +4 more sources
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends. [PDF]
Asian Pac J Cancer Prev, 2023 Background: Endometrial cancer is the fifteenth most common malignant disease in the world. It is estimated that 417,367 new cases of this malignant neoplasm are diagnosed annually and 97,370 women die from it.
Azhetova Z +17 more
europepmc +2 more sources
Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis. [PDF]
Front Oncol, 2022 Background Radiation therapy (RT) is a standard treatment for the local control of primary pelvic cancers (PPC), yet the risk of second corpus uteri cancer (SCUC) in PPC patients undergoing RT is still controversial. This study investigated the impact of
Yu G +8 more
europepmc +2 more sources